Matthieu Roustit (Roustit Matthieu)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 16

Top Topics

Plasmodium Falciparum

Polycyclic Aromatic Hydrocarbons

Top Venues

British journal of clinical pharmacology

Expert opinion on drug safety

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Ariane Jullien, Clément Jambon-Barbara, Jean-Luc Cracowski, Brian L Claggett, Anne-Laure Borel, Charles Khouri, Matthieu Roustit
Regional Heterogeneity of the Results of Glucagon-Like Peptide 1 Receptor Agonist Trials in Type 2 Diabetes: A Reanalysis of Individual Participant Data. Diabetes care (2024)
Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard, Matthieu Roustit, Charles Khouri
Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic. Expert opinion on drug safety 23 (8) (2024)
Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard, Matthieu Roustit, Charles Khouri
Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic. Expert opinion on drug safety (2024)
Jean-Luc Cracowski, Mathieu Molimard, Vincent Richard, Matthieu Roustit, Charles Khouri
Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic. Expert opinion on drug safety 23 (8) (2024)
Alicia Guigui, Léa Liaigre, Marc Manceau, Olivier Gaget, Jean-Luc Cracowski, Sophie Blaise, Charles Khouri, Matthieu Roustit
Assessment of digital perfusion as a surrogate outcome in Raynaud's phenomenon clinical trials. Rheumatology (Oxford, England) (2023)
Alex Hlavaty, Matthieu Roustit, I David Montani, Marie-Camille Chaumais, Christophe Guignabert, Marc Humbert, Jean-Luc Cracowski, Charles Khouri
Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis. British journal of clinical pharmacology 88 (12) (2022)
Justine Perez, Matthieu Roustit, Marion Lepelley, Bruno Revol, Jean-Luc Cracowski, Charles Khouri
Reported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic. Annals of internal medicine 174 (6) (2021)
Raymond Merle, Christophe Pison, Sophie Logerot, Chrystèle Deschaux, Nathalie Arnol, Matthieu Roustit, Renaud Tamisier, Jean Louis Pépin, Jean-Christian Borel
Peer-driven intervention to help patients resume CPAP therapy following discontinuation: a multicentre, randomised clinical trial with patient involvement. BMJ open 11 (10) (2021)
Matthieu Roustit, Marie-Camille Chaumais, Claire Chapuis, Anne Gairard-Dory, Caroline Hadjadj, Sébastien Chanoine, Benoît Allenet, Olivier Sitbon, Christophe Pison, Pierrick Bedouch, null null
Evaluation of a collaborative care program for pulmonary hypertension patients: a multicenter randomized trial. International journal of clinical pharmacy 42 (4) (2020)
Elodie Gautier-Veyret, Anne Thiebaut-Bertrand, Matthieu Roustit, Léa Bolcato, Julie Depeisses, Mathilde Schacherer, Gabriel Schummer, Xavier Fonrose, Françoise Stanke-Labesque
Optimization of voriconazole therapy for treatment of invasive aspergillosis: Pharmacogenomics and inflammatory status need to be evaluated. British journal of clinical pharmacology 87 (6) (2020)
Georgios Theocharidis, Dimitrios Baltzis, Matthieu Roustit, Ana Tellechea, Seema Dangwal, Radhika S Khetani, Bin Shu, Wanni Zhao, Jianfang Fu, Swati Bhasin, Antonios Kafanas, Daniel Hui, Shannan Ho Sui, Nikolaos A Patsopoulos, Manoj Bhasin, Aristidis Veves
Integrated Skin Transcriptomics and Serum Multiplex Assays Reveal Novel Mechanisms of Wound Healing in Diabetic Foot Ulcers. Diabetes 69 (10) (2020)
Putkaradze Zaza, Matthieu Roustit, Cracowski Jean-Luc, Charles Khouri
Drug repurposing in Raynaud's phenomenon through adverse event signature matching in the World Health Organization pharmacovigilance database. British journal of clinical pharmacology 86 (11) (2020)
Charles Khouri, Bruno Revol, Jean-Luc Cracowski, Matthieu Roustit
Proton pump inhibitors and Raynaud's phenomenon: is there a link? British journal of clinical pharmacology 84 (10) (2018)
Charles Khouri, Jean-Luc Cracowski, Matthieu Roustit
SGLT-2 inhibitors and the risk of lower-limb amputation: Is this a class effect? Diabetes, obesity & metabolism 20 (6) (2018)
Charles Khouri, Thomas Gailland, Marion Lepelley, Matthieu Roustit, Jean-Luc Cracowski
Fluoxetine and Raynaud's phenomenon: friend or foe? British journal of clinical pharmacology 83 (10) (2017)
Matthieu Roustit, Céline Genty, Marion Lepelley, Sophie Blaise, Bérengère Fromy, Jean-Luc Cracowski, Jean-Luc Bosson
Amiloride treatment and increased risk of pressure ulcers in hospitalized patients. British journal of clinical pharmacology 82 (6) (2016)